Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...
The FDA is changing course, now saying it will review Moderna's new mRNA flu vaccine. Moderna stock jumped more than 6% after the FDA agreed to review the drugmaker's first flu shot of the season, ...
Officials are investigating a suspected outbreak of bird flu after a large number of dead or dying geese were discovered at parks in Gloucester Co.
33mon MSN
FDA to review mRNA vaccine
Two weeks ago, the FDA refused to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has reversed course.
Asian shares were higher Thursday after a rally on Wall Street that was led by computer chip giant Nvidia. U.S. futures edged lower and oil prices rose as media reports said the likelihood was rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results